<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

Nefropatia associata al SARS-CoV-2: cosa sappiamo finora

dc.creatorTsalouchos, Aris
dc.creatorSalvadori, Maurizio
dc.date2020-08-05
dc.date.accessioned2026-11-02T10:56:17Z
dc.descriptionAcute kidney injury (AKI) is a frequent complication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) attributable to i) hypotension and decreased kidney perfusion secondary to hemodynamic or hemostatic factors, ii) drug-induced nephrotoxicity, iii) cytokine storm syndrome related to sepsis. However: i) early new-onset proteinuria and hematuria in many patients, ii) the identification of SARS-CoV-2 viral load in precisely defined kidney compartments, iii) ultrastructural evidence of direct viral infection of the kidneys, and most importantly, iv) morphological alterations associated to cytopathic action induced by the virus support the existence of SARS-CoV-2 associated nephropathy. In addition, collapsing glomerulopathy reported in African American patients with underlying APOL1 kidney risk alleles and SARS-CoV-2 infection is the evidence of a distinct form of SARS-CoV-2 associated nephropathy, the APOL1-SARS-CoV2-associated nephropathy.
dc.identifierhttps://doi.org/10.33393/gcnd.2020.2166
dc.identifieroai:zenodo.org:14462527
dc.identifier.urihttps://library.dare.co.zw/handle/123456789/4846
dc.languageund
dc.publisherZenodo
dc.relationhttps://zenodo.org/communities/it-mirror/
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightsCreative Commons Attribution Non Commercial 4.0 International
dc.rightshttps://creativecommons.org/licenses/by-nc/4.0/legalcode
dc.titleNefropatia associata al SARS-CoV-2: cosa sappiamo finora
dc.typeinfo:eu-repo/semantics/article

Files

Collections